SP
ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ·Healthcare·Biotechnology
$9.68
+0.94%
Mkt Cap $850.04M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (9 analysts)
$25.50
Range $25.00 – $26.00
Implied Upside
+163.4%
Consensus $25.50 vs current $9.68
NASDAQ·Healthcare·Biotechnology
$9.68
+0.94%
Mkt Cap $850.04M
Buy
1
Hold
0
Sell
0
Price Target (9 analysts)
$25.50
Range $25.00 – $26.00
+163.4%
Consensus $25.50 vs current $9.68